NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

側流化驗的全球市場的預測 (到2027年) :各產品,各用途,各技術,各終端用戶

Global Lateral Flow Assays Market by Product (Kits & Reagents, Instruments), Application (Clinical Testing, Veterinary, Food Safety), Technique (Sandwich, Multiplex), End User (Hospital, Diagnostic Labs) - Global Forecast to 2027

出版商 SPER Market Research Pvt. Ltd. 商品編碼 1023345
出版日期 內容資訊 英文 285 Pages
商品交期: 最快1-2個工作天內
價格
側流化驗的全球市場的預測 (到2027年) :各產品,各用途,各技術,各終端用戶 Global Lateral Flow Assays Market by Product (Kits & Reagents, Instruments), Application (Clinical Testing, Veterinary, Food Safety), Technique (Sandwich, Multiplex), End User (Hospital, Diagnostic Labs) - Global Forecast to 2027
出版日期: 2021年08月17日內容資訊: 英文 285 Pages
簡介

全球側流化驗市場,預計至2027年達到140億美元,從2020年以9%的年複合成長率成長。該成長的主要原因,是感染疾病的擴大,老年人口增加,POC檢驗和家用側流化驗設備的需求增加。

本報告提供全球側流化驗市場相關調查分析,市場概要,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • COVID-19對側流化驗市場的影響

第5章 產業考察

  • 簡介
  • 產業趨勢

第6章 全球側流化驗市場:各產品

  • 套件、試劑
  • 側流領導者

第7章 全球側流化驗市場:各技術

  • 三明治法
  • 競爭法
  • 多工檢測法

第8章 全球側流化驗市場:各樣品

  • 血液樣品
  • 尿樣品
  • 唾液樣品
  • 其他樣品

第9章 全球側流化驗市場:各用途

  • 臨床試驗
  • 獸醫用診斷
  • 食品安全、環境實驗
  • 醫藥品開發、品質實驗

第10章 全球側流化驗市場:各終端用戶

  • 醫院、診所
  • 診斷研究所
  • 居家醫療
  • 製藥、生物科技企業
  • 其他終端用戶

第11章 全球側流化驗市場:各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他地區
    • 南美
    • 中東、非洲

第12章 競爭情形

  • 簡介
  • 市場佔有率分析:各主要企業
  • 競爭情形與趨勢

第13章 企業簡介

  • Abbott Laboratories (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Siemens AG (Germany)
  • Becton, Dickinson and Company (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories (US)
  • Thermo Fisher Scientific, Inc. (US)
  • PerkinElmer Inc. (US)
  • Hologic Inc. (US)
  • Quidel Corporation (US)
  • Merck KGaA (Germany)
  • Abcam plc (UK)
  • Surmodics IVD (US)
  • Chembio Diagnostic Systems, Inc. (US)
  • OraSure Technologies (US)
  • DCN Diagnostics (US)
  • Polysciences, Inc. (US)
  • Abingdon Health (UK)
  • BioPorto Diagnostics A/S (Denmark)
  • Microcoat Biotechnologie GmbH (Germany)
  • Scienion AG (Germany)
  • Senova GmbH (Germany)
  • Access Bio, Inc. (US)

第14章 附錄

目錄
Product Code: MEDE2106

The global lateral flow assays market is expected to grow at a CAGR of ~9% from 2020 to reach ~14 billion by 2027. The growth is primarily attributed to prevalence of infectious diseases, growing geriatric population, increasing demand for POC testing and home-based lateral flow assay devices. However, lower accuracy and high margin of error associated with lateral flow assays is expected to hinder the growth of the market.

By Product: The lateral flow readers segment to grow at highest CAGR

The lateral flow readers provide the quantitative analysis of lateral flow strips. The lateral flow readers are expected to grow at the highest CAGR during the forecast period. The growth can be mainly attributed to high sensitivity and ability to quantify and accurately capture and transmit data.

By Technique: Sandwich assays accounted for the largest market share in 2020

Sandwich assays segment accounted for the largest market share of the lateral flow assay market, by technique in 2020. The large market share is mainly attributed to higher sensitivity, specificity for larger analyte and wide use of these assays.

By Sample Type: Other samples segment expected to register highest growth

Based on sample type, other samples segment is expected to grow at the highest CAGR in the forecast period. The growth is mainly ascribed by increasing R&D investments and escalating demand for precise disease testing.

By Application: Clinical testing expected to hold largest share in the lateral flow assays market

By application, lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environment testing and drug development & quality testing. Clinical testing accounted for largest market share in the lateral flow assays market by application in 2020. This segment is further classified into pregnancy & fertility testing, infectious disease testing, cardiac marker testing, cholesterol testing/lipid profiles, drugs-of-abuse testing and other tests. The large share of this segment can be attributed to faster results for qualitative and quantitative analysis in POC testing.

By End User: Hospitals & clinics to dominate the lateral flow assays market

Hospitals & clinics segment accounted for largest share of the lateral flow segment market, by end user in 2020. The large share is mainly attributed to growing adoption of lateral flow assays, advantages over conventional testing and increased demand due to pandemic.

By Region: North America expected to dominate the regional market

North America is expected to dominate the lateral flow assays market by region. The large share is primarily attributed to prevalence of infectious diseases such as tuberculosis, Lyme disease, HIV/AIDS, increasing disposable income and rising geriatric population in the North America region. The pandemic has further boosted the market by increased investments in R&D. APAC is expected to register highest CAGR. The growth can be attributed to prevalence of chronic diseases, government initiatives and increasing healthcare expenditure in these countries.

Competitive Scenario

  • Abbott Laboratories (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Siemens AG (Germany)
  • Becton, Dickinson and Company (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories (US)
  • Thermo Fisher Scientific, Inc. (US)
  • PerkinElmer Inc. (US)
  • Hologic Inc. (US)
  • Quidel Corporation (US)
  • Merck KGaA (Germany)
  • Abcam plc (UK)
  • Surmodics IVD (US)
  • Chembio Diagnostic Systems, Inc. (US)
  • OraSure Technologies (US)
  • DCN Diagnostics (US)
  • Polysciences, Inc. (US)
  • Abingdon Health (UK)
  • BioPorto Diagnostics A/S (Denmark)
  • Microcoat Biotechnologie GmbH (Germany)
  • Scienion AG (Germany)
  • Senova GmbH (Germany)
  • and Access Bio, Inc. (US)

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Lateral Flow Assay Market

5. Industry Insights

  • 5.1. Introduction
  • 5.2. Industry Trends

6. Global Lateral Flow Assay Market, By Product, 2019-2027 (USD Million)

  • 6.1. Kits & reagents
  • 6.2. Lateral flow readers

7. Global Lateral Flow Assay Market, By Technique, 2019-2027 (USD Million)

  • 7.1. Sandwich Assays
  • 7.2. Competitive Assays
  • 7.3. Multiplex Detection Assays

8. Global Lateral Flow Assay Market, By Sample, 2019-2027 (USD Million)

  • 8.1. Blood Samples
  • 8.2. Urine Samples
  • 8.3. Saliva Samples
  • 8.4. Other Samples

9. Global Lateral Flow Assay Market, By Application, 2019-2027 (USD Million)

  • 9.1. Clinical Testing
  • 9.2. Veterinary Diagnostics
  • 9.3. Food safety & Environment Testing
  • 9.4. Drug Development & Quality Testing

10. Global Lateral Flow Assay Market, By End User, 2019-2027 (USD Million)

  • 10.1. Hospitals & Clinics
  • 10.2. Diagnostics Laboratories
  • 10.3. Home Care Settings
  • 10.4. Pharmaceutical & Biotechnology Companies
  • 10.5. Other End Users

11. Global Lateral Flow Assay Market, By Geography, 2019-2027 (USD Million)

  • 11.1. North America
    • 11.1.1. US
    • 11.1.2. Canada
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. UK
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of the World
    • 11.4.1. Latin America
    • 11.4.2. Middle East & Africa

12. Competitive Landscape

  • 12.1. Introduction
  • 12.2. Market Share Analysis, By Key Players (2020)
  • 12.3. Competitive Situation and Trends
    • 12.3.1. Product Launches
    • 12.3.2. Partnerships, Collaborations and Agreements
    • 12.3.3. Acquisitions
    • 12.3.4. Expansions
    • 12.3.5. Other Developments

13. Company Profiles

  • 13.1. Abbott Laboratories (US)
  • 13.2. F. Hoffman-La Roche Ltd. (Switzerland)
  • 13.3. Danaher Corporation (US)
  • 13.4. Siemens AG (Germany)
  • 13.5. Becton, Dickinson and Company (US)
  • 13.6. bioMerieux SA (France)
  • 13.7. Bio-Rad Laboratories (US)
  • 13.8. Thermo Fisher Scientific, Inc. (US)
  • 13.9. PerkinElmer Inc. (US)
  • 13.10. Hologic Inc. (US)
  • 13.11. Quidel Corporation (US)
  • 13.12. Merck KGaA (Germany)
  • 13.13. Abcam plc (UK)
  • 13.14. Surmodics IVD (US)
  • 13.15. Chembio Diagnostic Systems, Inc. (US)
  • 13.16. OraSure Technologies (US)
  • 13.17. DCN Diagnostics (US)
  • 13.18. Polysciences, Inc. (US)
  • 13.19. Abingdon Health (UK)
  • 13.20. BioPorto Diagnostics A/S (Denmark)
  • 13.21. Microcoat Biotechnologie GmbH (Germany)
  • 13.22. Scienion AG (Germany)
  • 13.23. Senova GmbH (Germany)
  • 13.24. Access Bio, Inc. (US)

14. Appendix